logo
  

AT&T Aims To Help Businesses Reduce A Gigaton Of Global Emissions By 2035

Telecom major AT&T Inc. (T) said Tuesday that it has set a target to eliminate 1 billion metric tons of greenhouse gas or GHG emissions by 2035.

Through the AT&T Connected Climate Initiative, the company expects to help businesses collectively reduce a gigaton of GHG emissions. A gigaton is equal to around 15% of U.S. greenhouse gas emissions and nearly 3% of global energy-related emissions in 2020.

The company is working with businesses including Microsoft, Equinix, and Duke Energy, along with research universities, and a range of other organizations to deliver broadband-enabled climate solutions at global scale.

Charlene Lake, chief sustainability officer, AT&T, said, "Ubiquitous connectivity — nationwide broadband, which includes 5G access, for businesses everywhere — has the power to help scale technologies, dramatically accelerating business efforts to reach their climate goals. As AT&T advocates for universal broadband, we see an opportunity to support even more businesses in the transition to a net-zero economy through our global reach, advanced network capabilities and collaborations with industry and NGO partners."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's Cyltezo as the first interchangeable biosimilar to AbbVie's top-selling drug Humira or adalimumab. Cyltezo, originally approved in August 2017, is both biosimilar to, and interchangeable with Humira for Cyltezo's approved uses. The Food and Drug Administration may be planning to allow people to receive Covid-19 vaccine booster shot that is different from the initial dose, reports indicate. The agency is likely to make the announcement on mix and match approach on coronavirus booster vaccines on Wednesday. The move will be part of FDA's expected authorization of boosters for the Moderna and Johnson & Johnson vaccines. Drug major Johnson & Johnson on Tuesday raised again its forecast for fiscal 2021 earnings and sales, which are above market view, after reporting higher results in the third quarter. The company's quarterly adjusted earnings also beat market estimates. In pre-market activity on the NYSE, JNJ shares were gaining around 1.24 percent to trade at $162.10.
Follow RTT